Ching KA - Search Results

1

Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871).

Pavlicek A, Lira ME, Lee NV, Ching KA, Ye J, Cao J, Garza SJ, Hook KE, Ozeck M, Shi ST, Yuan J, Zheng X, Rejto PA, Kan JL, Christensen JG. Pavlicek A, et al. Among authors: ching ka. Mol Cancer Ther. 2013 Dec;12(12):2929-39. doi: 10.1158/1535-7163.MCT-13-0442-T. Epub 2013 Oct 9. Mol Cancer Ther. 2013. PMID: 24107449

2

An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.

Hook KE, Garza SJ, Lira ME, Ching KA, Lee NV, Cao J, Yuan J, Ye J, Ozeck M, Shi ST, Zheng X, Rejto PA, Kan JL, Christensen JG, Pavlicek A. Hook KE, et al. Among authors: ching ka. Mol Cancer Ther. 2012 Mar;11(3):710-9. doi: 10.1158/1535-7163.MCT-11-0184. Epub 2012 Jan 5. Mol Cancer Ther. 2012. PMID: 22222631

3

PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.

Wang K, Zhang Q, Li D, Ching K, Zhang C, Zheng X, Ozeck M, Shi S, Li X, Wang H, Rejto P, Christensen J, Olson P. Wang K, et al. Clin Cancer Res. 2015 Mar 15;21(6):1487-96. doi: 10.1158/1078-0432.CCR-14-1348. Epub 2015 Jan 6. Clin Cancer Res. 2015. PMID: 25564152

4

Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer.

Nam HJ, Ching KA, Kan J, Kim HP, Han SW, Im SA, Kim TY, Christensen JG, Oh DY, Bang YJ. Nam HJ, et al. Among authors: ching ka. Mol Cancer Ther. 2012 Feb;11(2):439-51. doi: 10.1158/1535-7163.MCT-11-0494. Epub 2011 Dec 1. Mol Cancer Ther. 2012. PMID: 22135232

5

A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation.

Lee NV, Lira ME, Pavlicek A, Ye J, Buckman D, Bagrodia S, Srinivasa SP, Zhao Y, Aparicio S, Rejto PA, Christensen JG, Ching KA. Lee NV, et al. Among authors: ching ka. PLoS One. 2012;7(6):e39653. doi: 10.1371/journal.pone.0039653. Epub 2012 Jun 22. PLoS One. 2012. PMID: 22745804 Free PMC article.

6

Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma.

Diamond JR, Salgia R, Varella-Garcia M, Kanteti R, LoRusso PM, Clark JW, Xu LG, Wilner K, Eckhardt SG, Ching KA, Lira ME, Schoenmakers EF, Christensen JG, Camidge DR. Diamond JR, et al. Among authors: ching ka. J Clin Oncol. 2013 Jun 1;31(16):e254-8. doi: 10.1200/JCO.2012.46.4289. Epub 2013 Apr 22. J Clin Oncol. 2013. PMID: 23610116 Free PMC article. No abstract available.

7

Cell Index Database (CELLX): a web tool for cancer precision medicine.

Ching KA, Wang K, Kan Z, Fernandez J, Zhong W, Kostrowicki J, Xie T, Zhu Z, Martini JF, Koehler M, Arndt K, Rejto P. Ching KA, et al. Pac Symp Biocomput. 2015:10-9. Pac Symp Biocomput. 2015. PMID: 25592564 Free article.

8

Decoding complex patterns of genomic rearrangement in hepatocellular carcinoma.

Fernandez-Banet J, Lee NP, Chan KT, Gao H, Liu X, Sung WK, Tan W, Fan ST, Poon RT, Li S, Ching K, Rejto PA, Mao M, Kan Z. Fernandez-Banet J, et al. Genomics. 2014 Feb-Mar;103(2-3):189-203. doi: 10.1016/j.ygeno.2014.01.003. Epub 2014 Jan 21. Genomics. 2014. PMID: 24462510 Free article. Clinical Trial.

9

Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome.

Park YH, Lal S, Lee JE, Choi YL, Wen J, Ram S, Ding Y, Lee SH, Powell E, Lee SK, Yu JH, Ching KA, Nam JY, Kim SW, Nam SJ, Kim JY, Cho SY, Park S, Kim J, Hwang S, Kim YJ, Bonato V, Fernandez D, Deng S, Wang S, Shin H, Kang ES, Park WY, Rejto PA, Bienkowska J, Kan Z. Park YH, et al. Among authors: ching ka. Nat Commun. 2020 Dec 2;11(1):6175. doi: 10.1038/s41467-020-19933-0. Nat Commun. 2020. PMID: 33268821 Free PMC article.

10

Activation of heterotrimeric GTP-binding proteins upon TCR/CD3 engagement.

Tsoukas CD, Stanners J, Ching KA. Tsoukas CD, et al. Among authors: ching ka. Methods Mol Biol. 2000;134:319-24. doi: 10.1385/1-59259-682-7:319. Methods Mol Biol. 2000. PMID: 10730270 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page